Fig. 2From: Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC)Trial timetable. MHRA Medicine and Healthcare products Regulatory Agency, NHS National Health Service, R&D Research and Development, REC Research ethics committeeBack to article page